Late-life treatment with the GLP-1 receptor agonist semaglutide extended lifespan, preserved physical function, and improved memory in female mice.
“Semaglutide shifted gene activity toward this maintenance work and away from inflammation, changes that overlapped with those associated with calorie restriction. It also reduced signs of protein-folding stress in stem cells that produce blood cells and neurons.”